Zonisamide for prevention of Atypical (Second generation) antipsychotics associated weight gain in schizophrenia
Phase 2
- Conditions
- schizophrenia.Schizophrenia
- Registration Number
- IRCT201103283930N5
- Lead Sponsor
- Vice chancellor for research, Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 56
Inclusion Criteria
Inclusion criteria are: age range of 16 to 65; lack of any reported neurological disease; lack of reported thyroid function problem; lack of current active substance use; lack of taking medication leading to significant weight gain or loss; no taking sulfanomides; lack of self reported kidney stone. Exclusion criteria are: lack of providing written consent; any serious medical condition such as epilepsy, thyroid function problems, diabetes; breast feeding; pregnancy; any special nutritional regime or intensive exercise program to decease weight.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hight. Timepoint: preintervention, weeks of 4, 8, and 10. Method of measurement: centimeter.;Weight. Timepoint: preintervention, weeks of 4, 8, and 10. Method of measurement: kilogram.;Waist circumference. Timepoint: preintervention, weeks of 4, 8, and 10. Method of measurement: Centimeter.
- Secondary Outcome Measures
Name Time Method